XELJANZ
11MG TBL PRO 91
SÚKL code | 0238764 |
---|---|
Name of the product | XELJANZ |
_MA_MEDICATION_DETAIL_INFO_MED_NAME i | XELJANZ |
Supplement | 11MG TBL PRO 91 |
Strenght | 11MG |
Pharmaceutical form | Prolonged-release tablet |
Package | 91 |
Route | Oral use |
Wrap type | Blister |
Legal status | na lékařský předpis |
Active substance | TOFACITINIB CITRATE (TOFACITINIBI CITRAS) |
ATC group | L04AA29 |
ATC group name | TOFACITINIB |
Marketing authorisation information
Registration Number | EU/1/17/1178/013 |
---|---|
Type of MA | centralised without orphans |
MA status | R - active MA/authorised medicinal product |
MA Holder | Pfizer Europe MA EEIG, Bruxelles |
MA Holder country | BELGIE |